{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=38", "query": { "intervention": "Intervention 2 - Sham Treatment", "page": 38 }, "page_size": 10 }, "pagination": { "page": 38, "page_size": 10, "total_count": 1790, "total_pages": 179, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=39&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intervention+2+-+Sham+Treatment&page=37&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T14:09:52.907Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05009498", "title": "Vitamin D3 Supplementation for Vitamin D Deficiency in Rotator Cuff Repair Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vitamin D Deficiency", "Rotator Cuff Tears" ], "interventions": [ { "name": "Vitamin D3 supplementation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Community Memorial Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 240, "start_date": "2021-09-01", "completion_date": "2024-08-01", "has_results": false, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 2, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" }, { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05009498" }, { "nct_id": "NCT02920892", "title": "AFQ056 for Language Learning in Children With FXS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fragile X Syndrome" ], "interventions": [ { "name": "AFQ056", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Language Intervention", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Elizabeth Berry-Kravis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "32 Months", "maximum_age": "6 Years", "sex": "ALL", "summary": "32 Months to 6 Years" }, "enrollment_count": 110, "start_date": "2017-08-17", "completion_date": "2022-05-17", "has_results": true, "last_update_posted_date": "2023-10-10", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 14, "location_summary": "Davis, California • Denver, Colorado • New Haven, Connecticut + 11 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02920892" }, { "nct_id": "NCT02942771", "title": "A MAD Study of TT301/MW189 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adult Volunteers" ], "interventions": [ { "name": "0.075mg/kg TT301/MW189", "type": "DRUG" }, { "name": "0.15mg/kg TT301MW189", "type": "DRUG" }, { "name": "0.25mg/kg TT301/MW189", "type": "DRUG" }, { "name": "0.30mg/kg TT301/MW189", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Linda Van Eldik", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 35, "start_date": "2017-03-20", "completion_date": "2018-06-04", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02942771" }, { "nct_id": "NCT04934371", "title": "Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tinnitus, Subjective", "Hyperacusis", "Hearing Disorders" ], "interventions": [ { "name": "Transcranial Direct Current Stimulation (tDCS)", "type": "DEVICE" }, { "name": "Sham TDCS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2025-01-15", "completion_date": "2025-12-15", "has_results": false, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04934371" }, { "nct_id": "NCT07075718", "title": "Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Gen 2 Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "Timolol eye drops 0.5%", "type": "DRUG" }, { "name": "Sham Procedure", "type": "PROCEDURE" }, { "name": "Placebo eye drops", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "Glaukos Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2025-06-12", "completion_date": "2032-03", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 3, "location_summary": "Grand Junction, Colorado • Oklahoma City, Oklahoma • El Paso, Texas", "locations": [ { "city": "Grand Junction", "state": "Colorado" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07075718" }, { "nct_id": "NCT06871124", "title": "Early Neuromodulation in Traumatic Brain Injury", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Brain Injury (TBI) Patients" ], "interventions": [ { "name": "transcranial electrical stimulation", "type": "DEVICE" }, { "name": "Sham Comparator", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2025-06-16", "completion_date": "2028-04-30", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06871124" }, { "nct_id": "NCT04710862", "title": "The Effects of Respiratory Training on Voice", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscle Tension Dysphonia" ], "interventions": [ { "name": "Breathing training without a device", "type": "BEHAVIORAL" }, { "name": "Breathing training with a device", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Syracuse University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2021-05-12", "completion_date": "2024-09-23", "has_results": true, "last_update_posted_date": "2025-07-24", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Syracuse, New York", "locations": [ { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04710862" }, { "nct_id": "NCT07214974", "title": "Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Mild Cognitive Impairment (MCI)", "Early Stages of Cognitive Decline", "Alzheimer's Disease Dementia", "Alzheimer's Disease Diagnosis", "Alzheimer's Disease and Related Dementias", "Parkinson's Disease", "Parkinson's Disease (PD)", "Parkinson's Disease With Wearing-off Motor Fluctuations", "Dementia (Diagnosis)", "Dementia MCI (Mild Cognitive Impairment)" ], "interventions": [ { "name": "Structured wellness care", "type": "BEHAVIORAL" }, { "name": "Wearable brain-computer interface devices", "type": "DEVICE" }, { "name": "Stem Cell Therapy - Experimental", "type": "BIOLOGICAL" }, { "name": "Control - Placebo Comparator", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE", "BIOLOGICAL", "OTHER" ], "sponsor": "Noah Tech, Corp.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 600, "start_date": "2026-09-01", "completion_date": "2030-01-03", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Palisades Park, New Jersey", "locations": [ { "city": "Palisades Park", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07214974" }, { "nct_id": "NCT04964089", "title": "A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Wet Age-related Macular Degeneration" ], "interventions": [ { "name": "KSI-301", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Kodiak Sciences Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 557, "start_date": "2021-06-23", "completion_date": "2023-04-06", "has_results": true, "last_update_posted_date": "2024-07-03", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 65, "location_summary": "Phoenix, Arizona • Springdale, Arkansas • Bakersfield, California + 60 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04964089" }, { "nct_id": "NCT00768690", "title": "A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HCV Infection" ], "interventions": [ { "name": "ABT-333", "type": "DRUG" }, { "name": "ketoconazole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 45, "start_date": "2008-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-10-13", "last_synced_at": "2026-11-05T14:09:52.907Z", "location_count": 1, "location_summary": "Waukegan, Illinois", "locations": [ { "city": "Waukegan", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00768690" } ] }